Evaluation of the introduction of novel potassium binders in routine care; the Stockholm CREAtinine Measurements (SCREAM) project.

https://storage.unitedwebnetwork.com/files/1099/cdf341588164eb075330cadb7a8cbcd7.pdf
Evaluation of the introduction of novel potassium binders in routine care; the Stockholm CREAtinine Measurements (SCREAM) project.
Ailema
Gonzalez Ortiz
Catherine M Clase clase@mcmaster.ca Department of Medicine, McMaster University, Hamilton, Ontario, Canada Department of Health Research and Methodology, McMaster University, Hamilton, Ontario, Canada Ontario
Alessandro Bosi alessandro.bosi@ki.se Karolinska Institutet Department of Medical Epidemiology and Biostatistics Stockholm
Edouard L Fu edfu@bwh.harvard.edu Department of Medical Epidemiology and Biostatistics, Karolinska Institutet/6. Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands 5. Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts
Beatriz E Pérez-Guillé bettyepg@yahoo.com Instituto Nacional de Pediatría Translational Research Center Mexico City
Anne-Laure Faucon anne-laure.faucon@aphp.fr Department of Medical Epidemiology and Biostatistics Karolinska Institutet INSERM U1018, Department of Clinical Epidemiology, Centre for Epidemiology and Population Health Stockholm
Marie Evans marie.evans@ki.se Karolinska Institutet Department of Clinical Science, Intervention and Technology Stockholm
Carmine Zoccali carmine.zoccali@icloud.com CNR-IFC Clinical Epidemiology of Renal Diseases and Hypertension Reggio Calabria
Juan-Jesús Carrero juan.jesus.carrero@ki.se Karolinksa Institutet Department of Medical Epidemiology and Biostatistics Stockholm